GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » Purchase Of Investment

Proteome Sciences (LSE:PRM) Purchase Of Investment : £0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Proteome Sciences Purchase Of Investment?

Proteome Sciences's purchase of investment for the six months ended in Dec. 2023 was £0.00 Mil. It means Proteome Sciences spent £0.00 Mil on purchasing investments. Proteome Sciences's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Jun. 2023 ), Proteome Sciences spent the same money on purchasing investments in Dec. 2023 (£0.00 Mil).

Proteome Sciences Purchase Of Investment Historical Data

The historical data trend for Proteome Sciences's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteome Sciences Purchase Of Investment Chart

Proteome Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Proteome Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Proteome Sciences Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteome Sciences Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Proteome Sciences's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteome Sciences (LSE:PRM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » Purchase Of Investment
Comparable Companies
LSE:ABDX LSE:GENI LSE:LLAI LSE:GDR LSE:VRCI LSE:AGL TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT SHSE:603259 LH DGX XPAR:BIM
Traded in Other Exchanges
PMSNF:USA PRM.GB:UK
Address
Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Website
https://www.proteomics.com
Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.